Many studies about the Alzheimer’s disease (AD) physiopathology suggest that the in vivo presence of insoluble fibrillar plaques of amyloid-β peptides weakly contributes to cognitive impairement and neurodegeneration1, 2, 3. This evidence concerns the gene PPIB and Alzheimer disease.